M 27 (Methylphenidate Hydrochloride Extended-Release 27 mg)
Pill with imprint M 27 is Gray, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 27 mg. It is supplied by Mallinckrodt, Inc.
Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 27 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for M 27
Methylphenidate Hydrochloride Extended-Release
- Imprint
- M 27
- Strength
- 27 mg
- Color
- Gray
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mallinckrodt, Inc.
- National Drug Code (NDC)
- 00406-0127
- Inactive Ingredients
-
microcrystalline cellulose,
hypromellose 2910 (6 mPa.s),
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
magnesium stearate,
medium-chain triglycerides,
oleic acid,
propylene glycol,
shellac,
silicon dioxide,
magnesium silicate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "M 27"
More about methylphenidate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (949)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: CNS stimulants
Patient resources
- Drug Information
- Methylphenidate transdermal
- Methylphenidate Oral, Transdermal (Advanced Reading)
- Methylphenidate Transdermal (Advanced Reading)
- Methylphenidate Chewable Tablets
- Other brands
- Concerta, Ritalin, Ritalin LA, Quillivant XR, ... +9 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.